Liang, B., Sadeghian Dehkord, E., Van hede, D., Barzegari, M., Verlee, B., Pirson, J., Nolens, G., Lambert, F., & Geris, L. (03 December 2023). Model-Based Design to Enhance Neotissue Formation in Additively Manufactured Calcium-Phosphate-Based Scaffolds. Journal of Functional Biomaterials, 14 (563), 22. doi:10.3390/jfb14120563 |
Nolens, G., Pignon, J.-C., Koopmansch, B., Elmoualij, B., Zorzi, W., De Pauw, E., & Winkler, R. (11 November 2009). Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines. Breast Cancer Research, 11 (6). doi:10.1186/bcr2450 |
Nolens, G. (2009). Identification de protéines interagissant avec les facteurs de transcription AP-2 et contribuant à la surexpression du gène ERBB2 dans le cancer du sein [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315227 |
Pignon, J.-C., Koopmansch, B., Nolens, G., Delacroix, L., Waltregny, D., & Winkler, R. (01 April 2009). Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Cancer Research, 69 (7), 2941-2949. doi:10.1158/0008-5472.CAN-08-3760 |
Allouche, A., Nolens, G., Tancredi, A., Delacroix, L., Mardaga, J., Fridman, V., Winkler, R., Boniver, J., Delvenne, P., & Begon, D. (January 2008). The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Research, 10 (1), 9. doi:10.1186/bcr1851 |
Chatel, G., Ganeff, C., Boussif, N., Delacroix, L., Briquet, A., Nolens, G., & Winkler, R. (15 December 2007). Hedgehog signaling pathway is inactive in colorectal cancer cell lines. International Journal of Cancer, 121 (12), 2622-2627. doi:10.1002/ijc.22998 |